Is trastuzumab associated with adverse cardiac effects in patients with breast cancer?

被引：0
|
作者：
Michael S Ewer
Daniel J Lenihan
机构：
[1] MS Ewer is Professor of Medicine and Special Assistant to the Vice President,
[2] and DJ Lenihan is Associate Professor of Medicine and Director of Cardiac Clinical Research,undefined
[3] at the University of Texas MD Anderson Cancer Center,undefined
[4] Houston,undefined
[5] TX,undefined
[6] USA.,undefined
来源：
Nature Clinical Practice Oncology | 2008年 / 5卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：192 / 193
页数：1
相关论文
共 50 条
  • [1] Is trastuzumab associated with adverse cardiac effects in patients with breast cancer?
    Ewer, Michael S.
    Lenihan, Daniel J.
    [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (04): : 192 - 193
  • [2] Cardiovascular adverse effects of trastuzumab in patients with stage IV breast cancer.
    Keefe, DL
    Spaltro, B
    Pierri, MK
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P6 - P6
  • [3] Signal Detection of Adverse Events Associated with Trastuzumab in a Cohort of Elderly Patients with Breast Cancer
    Polychronopoulou, Efstathia
    Giordano, Sharon H.
    Chou, Lin-Na
    Yu, Xiaoying
    Kuo, Yong-Fang
    [J]. ONCOLOGIST, 2022, 27 (06): : 434 - 440
  • [4] Cardiac side effects of trastuzumab in breast cancer patients - single centere experiences
    Huszno, Joanna
    Les, Dominika
    Sarzyczny-Slola, Danuta
    Nowara, Elzbieta
    [J]. WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2013, 17 (02): : 190 - 195
  • [5] Cardiac toxicity of trastuzumab in elderly patients with breast cancer
    Denegri, Andrea
    Moccetti, Tiziano
    Moccetti, Marco
    Spallarossa, Paolo
    Brunelli, Claudio
    Ameri, Pietro
    [J]. JOURNAL OF GERIATRIC CARDIOLOGY, 2016, 13 (04) : 355 - 363
  • [6] Cardiac toxicity of trastuzumab in elderly patients with breast cancer
    Andrea Denegri
    Tiziano Moccetti
    Marco Moccetti
    Paolo Spallarossa
    Claudio Brunelli
    Pietro Ameri
    [J]. Journal of Geriatric Cardiology, 2016, 13 (04) : 355 - 363
  • [7] Analysis of Adverse Events Associated with Trastuzumab Deruxtecan in Patients with Gastric and Breast Cancer: A Retrospective Study
    Nonomiya, Yuma
    Nakayama, Izuma
    Kobayashi, Kazuo
    Amakawa, Yoshihiro
    Shibata, Naoki
    Soejima, Azusa
    Kawakami, Kazuyoshi
    Shimizu, Hisanori
    Takahari, Daisuke
    Kawai, Saori
    Hara, Fumikata
    Takano, Toshimi
    Yamaguchi, Kensei
    Yamaguchi, Masakazu
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2024, 47 (02) : 411 - 416
  • [8] Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial
    Suter, Thomas M.
    Procter, Marion
    van Veldhuisen, Dirk J.
    Muscholl, Michael
    Bergh, Jonas
    Carlomagno, Chiara
    Perren, Timothy
    Passalacqua, Rodolfo
    Bighin, Claudia
    Klijn, Jan G. M.
    Ageev, Fail T.
    Hitre, Erika
    Groetz, Juergen
    Iwata, Hiroji
    Knap, Malgorzata
    Gnant, Michael
    Muehlbauer, Susanne
    Spence, Alison
    Gelber, Richard D.
    Piccart-Gebhart, Martine J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (25) : 3859 - 3865
  • [9] Reversible and Irreversible Cardiac Dysfunction Associated with Trastuzumab in Breast Cancer
    Yee-Lu Tham
    Mario S Verani
    Jenny Chang
    [J]. Breast Cancer Research and Treatment, 2002, 74 : 131 - 134
  • [10] Reversible and irreversible cardiac dysfunction associated with trastuzumab in breast cancer
    Tham, YL
    Verani, MS
    Chang, J
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2002, 74 (02) : 131 - 134
12345